Quick Answer
TriSalus Life Sciences, Inc. reported Net Income Loss of -$39.23 million for the year ending 2025.
- TriSalus Life Sciences, Inc. showed a decrease of -30.6% in Net Income Loss from 2024 to 2025.
- This data is from TriSalus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), TriSalus Life Sciences, Inc.'s Net Income Loss has declined by 922.8%.
- Historical annual values: Fiscal year 2025: -$39.23 million | Fiscal year 2024: -$30.05 million | Fiscal year 2023: -$59.36 million | Fiscal year 2022: -$47.19 million | Fiscal year 2021: $4.77 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: